45 results on '"Clementi, Francesco"'
Search Results
2. Auxiliary protein and chaperone regulation of neuronal nicotinic receptor subtype expression and function.
- Author
-
Gotti C, Clementi F, and Zoli M
- Subjects
- Neurons metabolism, Synaptic Transmission, Molecular Chaperones metabolism, Cell Membrane metabolism, Receptors, Nicotinic genetics
- Abstract
Neuronal nicotinic acetylcholine receptors (nAChRs) are a family of pentameric, ligand-gated ion channels that are located on the surface of neurons and non-neuronal cells and have multiple physiological and pathophysiological functions. In order to reach the cell surface, many nAChR subtypes require the help of chaperone and/or auxiliary/accessory proteins for their assembly, trafficking, pharmacological modulation, and normal functioning in vivo. The use of powerful genome-wide cDNA screening has led to the identification and characterisation of the molecules and mechanisms that participate in the assembly and trafficking of receptor subtypes, including chaperone and auxiliary or accessory proteins. The aim of this review is to describe the latest findings concerning nAChR chaperones and auxiliary proteins and pharmacological chaperones, and how some of them control receptor biogenesis or regulate channel activation and pharmacology. Some auxiliary proteins are subtype selective, some regulate various subtypes, and some not only modulate nAChRs but also target other receptors and signalling pathways. We also discuss how changes in auxiliary proteins may be involved in nAChR dysfunctions., Competing Interests: Declaration of Competing Interest The authors declare that there is no financial/personal interest or belief that could affect their objectivity., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. Subnanomolar Affinity and Selective Antagonism at α7 Nicotinic Receptor by Combined Modifications of 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624).
- Author
-
Bavo F, Pallavicini M, Pucci S, Appiani R, Giraudo A, Oh H, Kneisley DL, Eaton B, Lucero L, Gotti C, Clementi F, Whiteaker P, and Bolchi C
- Subjects
- Ether, alpha7 Nicotinic Acetylcholine Receptor, Ethyl Ethers, Ethers, Receptors, Nicotinic
- Abstract
Modifications of the cationic head and the ethylene linker of 2-(triethylammonium)ethyl ether of 4-stilbenol (MG624) have been proved to produce selective α9*-nAChR antagonism devoid of any effect on the α7-subtype. Here, single structural changes at the styryl portion of MG624 lead to prevailing α7-nAChR antagonism without abolishing α9*-nAChR antagonism. Nevertheless, rigidification of the styryl into an aromatic bicycle, better if including a H-bond donor NH, such as 5-indolyl ( 31 ), resulted in higher and more selective α7-nAChR affinity. Hybridization of this modification with the constraint of the 2-triethylammoniumethyloxy portion into ( R )- N,N -dimethyl-3-pyrrolidiniumoxy substructure, previously reported as the best modification for the α7-nAChR affinity of MG624 ( 2 ), was a winning strategy. The resulting hybrid 33 had a subnanomolar α7-nAChR affinity and was a potent and selective α7-nAChR antagonist, producing at the α7-, but not at the α9*-nAChR, a profound loss of subsequent ACh function.
- Published
- 2023
- Full Text
- View/download PDF
4. Cytisine and cytisine derivatives. More than smoking cessation aids.
- Author
-
Gotti C and Clementi F
- Subjects
- Alkaloids pharmacokinetics, Alkaloids toxicity, Animals, Azocines pharmacokinetics, Azocines pharmacology, Azocines toxicity, Humans, Molecular Structure, Nervous System metabolism, Quinolizines pharmacokinetics, Quinolizines pharmacology, Quinolizines toxicity, Receptors, Nicotinic metabolism, Smoking Cessation Agents pharmacokinetics, Smoking Cessation Agents toxicity, Structure-Activity Relationship, Alkaloids pharmacology, Nervous System drug effects, Receptors, Nicotinic drug effects, Smoking Cessation, Smoking Cessation Agents pharmacology
- Abstract
Cytisine, a natural bioactive compound that is mainly isolated from plants of the Leguminosae family (especially the seeds of Laburnum anagyroides), has been marketed in central and eastern Europe as an aid in the clinical management of smoking cessation for more than 50 years. Its main targets are neuronal nicotinic acetylcholine receptors (nAChRs), and pre-clinical studies have shown that its interactions with various nAChR subtypes located in different areas of the central and peripheral nervous systems are neuroprotective, have a wide range of biological effects on nicotine and alcohol addiction, regulate mood, food intake and motor activity, and influence the autonomic and cardiovascular systems. Its relatively rigid conformation makes it an attractive template for research of new derivatives. Recent studies of structurally modified cytisine have led to the development of new compounds and for some of them the biological activities are mediated by still unidentified targets other than nAChRs, whose mechanisms of action are still being investigated. The aim of this review is to describe and discuss: 1) the most recent pre-clinical results obtained with cytisine in the fields of neurological and non-neurological diseases; 2) the effects and possible mechanisms of action of the most recent cytisine derivatives; and 3) the main areas warranting further research., (Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
5. Choline and nicotine increase glioblastoma cell proliferation by binding and activating α7- and α9- containing nicotinic receptors.
- Author
-
Pucci S, Fasoli F, Moretti M, Benfante R, Di Lascio S, Viani P, Daga A, Gordon TJ, McIntosh M, Zoli M, Clementi F, and Gotti C
- Subjects
- Cell Line, Tumor, Cell Proliferation drug effects, Humans, MAP Kinase Signaling System drug effects, Proto-Oncogene Proteins c-akt metabolism, RNA, Small Interfering genetics, Receptors, Nicotinic genetics, alpha7 Nicotinic Acetylcholine Receptor genetics, Brain Neoplasms metabolism, Choline pharmacology, Glioblastoma metabolism, Nicotine pharmacology, Receptors, Nicotinic metabolism, alpha7 Nicotinic Acetylcholine Receptor metabolism
- Abstract
Glioblastomas (GBMs), the most frequent and aggressive human primary brain tumours, have altered cell metabolism, and one of the strongest indicators of malignancy is an increase in choline compounds. Choline is also a selective agonist of some neuronal nicotinic acetylcholine receptor (nAChR) subtypes. As little is known concerning the expression of nAChR in glioblastoma cells, we analysed in U87MG human grade-IV astrocytoma cell line and GBM5 temozolomide-resistant glioblastoma cells selected from a cancer stem cell-enriched culture, molecularly, pharmacologically and functionally which nAChR subtypes are expressed and,whether choline and nicotine can affect GBM cell proliferation. We found that U87MG and GBM5 cells express similar nAChR subtypes, and choline and nicotine increase their proliferation rate and activate the anti-apoptotic AKT and pro-proliferative ERK pathways. These effects are blocked by the presence of non-cell-permeable peptide antagonists selective for α7- and α9-containing nicotinic receptors. siRNA-mediated silencing of α7 or α9 subunit expression also selectively prevents the effects of nicotine and choline on GBM cell proliferation. Our findings indicate that nicotine and choline activate the signalling pathways involved in the proliferation of GBM cells, and that these effects are mediated by α7 and α9-containing nAChRs. This suggests that these nicotinic receptors may contribute to the aggressive behaviour of this tumor and may indicate new therapeutic strategies against high-grade human brain tumours., (Copyright © 2020. Published by Elsevier Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
6. Potent Antiglioblastoma Agents by Hybridizing the Onium-Alkyloxy-Stilbene Based Structures of an α7-nAChR, α9-nAChR Antagonist and of a Pro-Oxidant Mitocan.
- Author
-
Bavo F, Pucci S, Fasoli F, Lammi C, Moretti M, Mucchietto V, Lattuada D, Viani P, De Palma C, Budriesi R, Corradini I, Dowell C, McIntosh JM, Clementi F, Bolchi C, Gotti C, and Pallavicini M
- Subjects
- Antineoplastic Agents chemistry, Antineoplastic Agents pharmacology, Cell Line, Tumor, Cell Proliferation drug effects, Humans, Glioblastoma pathology, Reactive Oxygen Species chemistry, Receptors, Nicotinic metabolism, Stilbenes chemistry, Stilbenes pharmacology, alpha7 Nicotinic Acetylcholine Receptor antagonists & inhibitors
- Abstract
Adenocarcinoma and glioblastoma cell lines express α7- and α9α10-containing nicotinic acetylcholine receptors (nAChRs), whose activation promotes tumor cell growth. On these cells, the triethylammoniumethyl ether of 4-stilbenol MG624, a known selective antagonist of α7 and α9α10 nAChRs, has antiproliferative activity. The structural analogy of MG624 with the mitocan RDM-4'BTPI, triphenylphosphoniumbutyl ether of pterostilbene, suggested us that molecular hybridization among their three substructures (stilbenoxy residue, alkylene linker, and terminal onium) and elongation of the alkylene linker might result in novel antitumor agents with higher potency and selectivity. We found that lengthening the ethylene bridge in the triethylammonium derivatives results in more potent and selective toxicity toward adenocarcinoma and glioblastoma cells, which was paralleled by increased α7 and α9α10 nAChR antagonism and improved ability of reducing mitochondrial ATP production. Elongation of the alkylene linker was advantageous also for the triphenylphosphonium derivatives resulting in a generalized enhancement of antitumor activity, associated with increased mitotoxicity.
- Published
- 2018
- Full Text
- View/download PDF
7. α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.
- Author
-
Mucchietto V, Fasoli F, Pucci S, Moretti M, Benfante R, Maroli A, Di Lascio S, Bolchi C, Pallavicini M, Dowell C, McIntosh M, Clementi F, and Gotti C
- Subjects
- A549 Cells, Adenocarcinoma metabolism, Adenocarcinoma pathology, Cell Line, Tumor, Cell Proliferation drug effects, Dose-Response Relationship, Drug, Humans, Lung Neoplasms metabolism, Lung Neoplasms pathology, Quaternary Ammonium Compounds pharmacology, Stilbenes pharmacology, Structure-Activity Relationship, alpha7 Nicotinic Acetylcholine Receptor metabolism, Adenocarcinoma drug therapy, Lung Neoplasms drug therapy, Nicotine pharmacology, Receptors, Nicotinic metabolism, alpha7 Nicotinic Acetylcholine Receptor antagonists & inhibitors
- Abstract
Background and Purpose: Tobacco smoke contains many classes of carcinogens and although nicotine is unable to initiate tumourigenesis in humans and rodents, it promotes tumour growth and metastasis in lung tumours by acting on neuronal nicotinic ACh receptors (nAChRs). The aim of this study was to identify molecularly, biochemically and pharmacologically which nAChR subtypes are expressed and functionally activated by nicotine in lung cancer cell lines., Experimental Approach: We used A549 and H1975 adenocarcinoma cell lines derived from lung tumours to test the in vitro effects of nicotine, and nAChR subtype-specific peptides and compounds., Key Results: The two adenocarcinoma cell lines express distinctive nAChR subtypes, and this affects their nicotine-induced proliferation. In A549 cells, nAChRs containing the α7 or α9 subunits not only regulate nicotine-induced cell proliferation but also the activation of the Akt and ERK pathways. Blocking these nAChRs by means of subtype-specific peptides, or silencing their expression by means of subunit-specific siRNAs, abolishes nicotine-induced proliferation and signalling. Moreover, we found that the α7 antagonist MG624 also acts on α9-α10 nAChRs, blocks the effects of nicotine on A549 cells and has dose-dependent cytotoxic activity., Conclusions and Implications: These results highlight the pathophysiological role of α7- and α9-containing receptors in promoting non-small cell lung carcinoma cell growth and intracellular signalling and provide a framework for the development of new drugs that specifically target the receptors expressed in lung tumours., Linked Articles: This article is part of a themed section on Nicotinic Acetylcholine Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.11/issuetoc., (© 2017 The British Pharmacological Society.)
- Published
- 2018
- Full Text
- View/download PDF
8. Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment.
- Author
-
Mucchietto V, Crespi A, Fasoli F, Clementi F, and Gotti C
- Subjects
- Cell Proliferation drug effects, Humans, Lung Neoplasms metabolism, Lung Neoplasms pathology, Polymorphism, Single Nucleotide genetics, Receptors, Nicotinic genetics, Antineoplastic Agents pharmacology, Cholinergic Agonists pharmacology, Lung Neoplasms drug therapy, Receptors, Nicotinic metabolism
- Abstract
Lung cancer is the leading cause of cancer-related deaths worldwide. Smoking accounts for approximately 70% of the cases of non- small cell lung cancer (NSCLC) and 90% of the cases of small-cell lung cancer (SCLC), although some patients develop lung cancer without a history of smoking. Nicotine is the most active addictive component of tobacco smoke. It does not initiate tumorigenesis in humans and rodents, but it alters the pathophysiology of lung cells by inducing the secretion of growth factors, neurotransmitters and cytokines, and promotes tumour growth and metastases by inducing cell cycle progression, migration, invasion, angiogenesis and the evasion of apoptosis. Most of these effects are a result of nicotine binding and activation of cell-surface neuronal nicotinic acetylcholine receptors (nAChRs) and downstream intracellular signalling cascades, and many are blocked by nAChR subtype-selective antagonists. Recent genome-wide association studies have revealed single nucleotide polymorphisms of nAChR subunits that influence nicotine dependence and lung cancer. This review describes the molecular basis of nAChR structural and functional diversity in normal and cancer lung cells, and the genetic alterations facilitating smoking-induced lung cancers. It also summarises current knowledge concerning the intracellular pathways activated by nicotine and other compounds present in tobacco smoke.
- Published
- 2016
- Full Text
- View/download PDF
9. The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptors.
- Author
-
Ponzoni L, Braida D, Pucci L, Andrea D, Fasoli F, Manfredi I, Papke RL, Stokes C, Cannazza G, Clementi F, Gotti C, and Sala M
- Subjects
- Animals, Benzazepines pharmacology, Quinoxalines pharmacology, Varenicline, Zebrafish, Alkaloids pharmacology, Conditioning, Operant drug effects, Nicotine pharmacology, Nicotinic Agonists pharmacology, Nicotinic Antagonists pharmacology, Receptors, Nicotinic metabolism
- Abstract
Rationale: Cigarette smoking is one of the most serious health problems worldwide and people trying to stop smoking have high rates of relapse. Zebrafish (Danio rerio), by combining pharmacological and behavioral assays, is a promising animal model for rapidly screening new compounds to induce smoking cessation., Objectives: This study aims to identify possible acetylcholine nicotinic receptors (nAChRs) involved in mediating nicotine (NIC)-induced conditioned place preference (CPP) in zebrafish and investigate the effect of the CC4 and CC26 cytisine derivatives in reducing NIC-induced CPP., Methods: CPP was evaluated using a two-compartment chamber, and the zebrafish were given CC4 (0.001-5 mg/kg), CC26 (0.001-1 mg/kg), cytisine (0.1-2.5 mg/kg), and varenicline (1-10 mg/kg) alone or with NIC (0.001 mg/kg). Swimming activity was evaluated using a square observational chamber. The affinity of the nicotinic ligands for native zebrafish brain nAChRs was evaluated by binding studies using [(3)H]-Epibatidine (Epi) and [(125)I]-αBungarotoxin (αBgtx) radioligands, and their subtype specificity was determined by means of electrophysiological assay of oocyte-expressed α4β2 and α7 subtypes., Results: CC4 and CC26 induced CPP with an inverted U-shaped dose-response curve similar to that of NIC. However, when co-administered with NIC, they blocked its reinforcing or slightly aversive effect. Binding and electrophysiological studies showed that this effect was due to binding to high-affinity heteromeric but not α7-containing receptors., Conclusions: We have further characterized CC4 and identified a new compound (CC26) that may be active in inducing smoking cessation. Zebrafish is a very useful model for screening new compounds that can affect the rewarding properties of NIC.
- Published
- 2014
- Full Text
- View/download PDF
10. Nicotine-modulated subunit stoichiometry affects stability and trafficking of α3β4 nicotinic receptor.
- Author
-
Mazzo F, Pistillo F, Grazioso G, Clementi F, Borgese N, Gotti C, and Colombo SF
- Subjects
- Animals, Antibodies pharmacology, Cell Membrane drug effects, Cell Membrane metabolism, Endoplasmic Reticulum drug effects, Endoplasmic Reticulum metabolism, HeLa Cells, Humans, Male, Models, Chemical, Mutagenesis physiology, Neuroblastoma, Nicotinic Agonists pharmacology, Proteasome Endopeptidase Complex metabolism, Rabbits, Receptors, Nicotinic chemistry, Receptors, Nicotinic genetics, Receptors, Nicotinic immunology, Smoking metabolism, Up-Regulation drug effects, Up-Regulation physiology, Nicotine pharmacology, Protein Transport drug effects, Protein Transport physiology, Receptors, Nicotinic metabolism, Smoking physiopathology
- Abstract
Heteromeric nAChRs are pentameric cation channels, composed of combinations of two or three α and three or two β subunits, which play key physiological roles in the central and peripheral nervous systems. The prototypical agonist nicotine acts intracellularly to upregulate many nAChR subtypes, a phenomenon that is thought to contribute to the nicotine dependence of cigarette smokers. The α3β4 subtype has recently been genetically linked to nicotine dependence and lung cancer; however, the mode of action of nicotine on this receptor subtype has been incompletely investigated. Here, using transfected mammalian cells as model system, we characterized the response of the human α3β4 receptor subtype to nicotine and the mechanism of action of the drug. Nicotine, when present at 1 mm concentration, elicited a ∼5-fold increase of cell surface α3β4 and showed a more modest upregulatory effect also at concentrations as low as 10 μM. Upregulation was obtained if nicotine was present during, but not after, pentamer assembly and was caused by increased stability and trafficking of receptors assembled in the presence of the drug. Experimental determinations as well as computational studies of subunit stoichiometry showed that nicotine favors assembly of pentamers with (α3)2(β4)3 stoichiometry; these are less prone than (α3)3(β4)2 receptors to proteasomal degradation and, because of the presence in the β subunit of an endoplasmic reticulum export motif, more efficiently transported to the plasma membrane. Our findings uncover a novel mechanism of nicotine-induced α3β4 nAChR upregulation that may be relevant also for other nAChR subtypes.
- Published
- 2013
- Full Text
- View/download PDF
11. CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.
- Author
-
Sala M, Braida D, Pucci L, Manfredi I, Marks MJ, Wageman CR, Grady SR, Loi B, Fucile S, Fasoli F, Zoli M, Tasso B, Sparatore F, Clementi F, and Gotti C
- Subjects
- Alkaloids chemistry, Animals, Azocines chemistry, Behavior, Animal drug effects, Drug Partial Agonism, Male, Mice, Mice, Inbred C57BL, Molecular Structure, Motor Activity drug effects, Nicotine administration & dosage, Nicotinic Agonists chemistry, Protein Binding, Quinolizines chemistry, Rats, Rats, Wistar, Self Administration, Tobacco Use Disorder drug therapy, Alkaloids pharmacology, Azocines pharmacology, Nicotinic Agonists pharmacology, Quinolizines pharmacology, Receptors, Nicotinic metabolism, Tobacco Use Cessation
- Abstract
Background and Purpose: Many of the addictive and rewarding effects of nicotine are due to its actions on the neuronal nicotinic ACh receptor (nAChR) subtypes expressed in dopaminergic mesocorticolimbic cells. The partial agonists, cytisine and varenicline, are helpful smoking cessation aids. These drugs have a number of side effects that limit their usefulness. The aim of this study was to investigate the preclinical pharmacology of the cytisine dimer1,2-bisN-cytisinylethane (CC4)., Experimental Approach: The effects of CC4 on nAChRs were investigated using in vitro assays and animal behaviours., Key Results: When electrophysiologically tested using heterologously expressed human subtypes, CC4 was less efficacious than cytisine on neuronal α4β2, α3β4, α7 and muscle-type receptors, and had no effect on 5-hydroxytryptamine3 receptors. Acting through α4β2 and α6β2 nAChRs, CC4 is a partial agonist of nAChR-mediated striatal dopamine release and, when co-incubated with nicotine, prevented nicotine's maximal effect on this response. In addition, it had low affinity for, and was less efficacious than nicotine and cytisine on the α3β4 and α7-nAChR subtypes. Like cytisine and nicotine, CC4-induced conditioned place preference (CPP), and its self-administration shows an inverted-U dose-response curve. Pretreatment with non-reinforcing doses of CC4 significantly reduced nicotine-induced self-administration and CPP without affecting motor functions., Conclusion and Implications: Our in vitro and in vivo findings reveal that CC4 selectively reduces behaviours associated with nicotine addiction consistent with the partial agonist selectivity of CC4 for β2-nAChRs. The results support the possible development of CC4 or its derivatives as a promising drug for tobacco smoking cessation., (© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.)
- Published
- 2013
- Full Text
- View/download PDF
12. The enantiomers of epiboxidine and of two related analogs: synthesis and estimation of their binding affinity at α4β2 and α7 neuronal nicotinic acetylcholine receptors.
- Author
-
Dallanoce C, Matera C, De Amici M, Rizzi L, Pucci L, Gotti C, Clementi F, and De Micheli C
- Subjects
- Animals, Chemistry Techniques, Synthetic, Isoxazoles chemistry, Protein Binding, Rats, Stereoisomerism, alpha7 Nicotinic Acetylcholine Receptor, Isoxazoles chemical synthesis, Isoxazoles metabolism, Neurons metabolism, Receptors, Nicotinic metabolism
- Abstract
Epiboxidine hydrochlorides (+)-2 and (-)-2, which are the structural analogs of the antipodes of epibatidine (±)-1, as well as the enantiomeric pairs (+)-3/(-)-3 and (+)-4/(-)-4 were synthesized and tested for binding affinity at α4β2 and α7 nicotinic acetylcholine receptor (nAChR) subtypes. Final derivatives were prepared through the condensation of racemic N-Boc-7-azabicyclo[2.2.1]heptane-2-one (±)-5 with the resolving agent (R)-(+)-2-methyl-2-propanesulfinamide. The pharmacological analysis carried out on the three new enantiomeric pairs evidenced an overall negligible degree of enantioselectivity at both nAChRs subtypes, a result similar to that reported for both natural and unnatural epibatidine enantiomers at the same investigated receptor subtypes., (© 2012 Wiley Periodicals, Inc.)
- Published
- 2012
- Full Text
- View/download PDF
13. Adolescent nicotine exposure transiently increases high-affinity nicotinic receptors and modulates inhibitory synaptic transmission in rat medial prefrontal cortex.
- Author
-
Counotte DS, Goriounova NA, Moretti M, Smoluch MT, Irth H, Clementi F, Schoffelmeer AN, Mansvelder HD, Smit AB, Gotti C, and Spijker S
- Subjects
- Adolescent, Animals, Chromatography, Liquid, Female, Humans, Immunoprecipitation, Nicotine metabolism, Pregnancy, Rats, Rats, Wistar, Spectrometry, Mass, Electrospray Ionization, Models, Animal, Nicotine administration & dosage, Prefrontal Cortex metabolism, Receptors, Nicotinic metabolism, Synaptic Transmission
- Abstract
Adolescence is a critical developmental period during which most adult smokers initiate their habit. Adolescents are more vulnerable than adults to nicotine's long-term effects on addictive and cognitive behavior. We investigated whether adolescent nicotine exposure in rats modifies expression of nicotinic acetylcholine receptors (nAChRs) in medial prefrontal cortex (mPFC) in the short and/or long term, and whether this has functional consequences. Using receptor binding studies followed by immunoprecipitation of nAChR subunits, we showed that adolescent nicotine exposure, as compared with saline, caused an increase in mPFC nAChRs containing α4 or β2 subunits (24 and 18%, respectively) 24 h after the last injection. Nicotine exposure in adulthood had no such effect. This increase was transient and was not observed 5 wk following either adolescent or adult nicotine exposure. In line with increased nAChRs expression 1 d after adolescent nicotine exposure, we observed a 34% increase in amplitude of nicotine-induced spontaneous inhibitory postsynaptic currents in layer II/III mPFC pyramidal neurons. These effects were transient and specific, and observed only acutely after adolescent nicotine exposure, but not after 5 wk, and no changes were observed in adult-exposed animals. The acute nicotine-induced increase in α4β2-containing receptors in adolescents interferes with the normal developmental decrease (37%) of these receptors from early adolescence (postnatal day 34) to adulthood (postnatal day 104) in the mPFC. Together, this suggests that these receptors play a role in mediating the acute rewarding effects of nicotine and may underlie the increased sensitivity of adolescents to nicotine.
- Published
- 2012
- Full Text
- View/download PDF
14. Synthesis and binding affinity at α4β2 and α7 nicotinic acetylcholine receptors of new analogs of epibatidine and epiboxidine containing the 7-azabicyclo[2.2.1]hept-2-ene ring system.
- Author
-
Dallanoce C, Matera C, Pucci L, Gotti C, Clementi F, Amici MD, and Micheli CD
- Subjects
- Binding Sites drug effects, Bridged Bicyclo Compounds, Heterocyclic chemical synthesis, Ligands, Molecular Structure, Pyridines chemical synthesis, Pyridines chemistry, Stereoisomerism, Structure-Activity Relationship, Bridged Bicyclo Compounds, Heterocyclic chemistry, Bridged Bicyclo Compounds, Heterocyclic pharmacology, Pyridines pharmacology, Receptors, Nicotinic chemistry
- Abstract
A group of novel racemic nicotinic ligands structurally related to epibatidine or epiboxidine [(±)-10-(±)-17] was synthesized through a palladium-catalyzed cross-coupling between the appropriate vinyl triflate and a range of organometallic heterocycles. The target compounds were evaluated for binding affinity at the α4β2 and α7 neuronal nicotinic receptors (nAChRs). The set of 3-pyridinyl derivatives (±)-10, (±)-11 and (±)-12 exhibited an affinity for the α4β2 nAChR subtype in the subnanomolar range (K(i) values of 0.20, 0.40 and 0.50nM, respectively) and behaved as α4β2 versus α7 subtype selective ligands. Interestingly, the epiboxidine-related dimethylammonium iodide (±)-17, which retained a good affinity for the α4β2 nAChR (K(i)=13.30nM), tightly bound also to the α7 subtype (K(i)=1.60nM), thus displaying a reversal of the affinity trend among the reference and new nicotinic ligands under investigation., (Copyright © 2011 Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
15. New spirocyclic Δ²-isoxazoline derivatives related to selective agonists of α7 neuronal nicotinic acetylcholine receptors.
- Author
-
Dallanoce C, Frigerio F, Grazioso G, Matera C, Visconti GL, De Amici M, Pucci L, Pistillo F, Fucile S, Gotti C, Clementi F, and De Micheli C
- Subjects
- Animals, Binding Sites, Cell Line, Humans, Models, Molecular, Protein Binding, Rats, alpha7 Nicotinic Acetylcholine Receptor, Isoxazoles chemistry, Isoxazoles pharmacology, Nicotinic Agonists chemistry, Nicotinic Agonists pharmacology, Receptors, Nicotinic metabolism
- Abstract
A set of structural analogues of spirocyclic quinuclidinyl-Δ(2)-isoxazolines, characterized as potent and selective α7 nicotinic agonists, was prepared and assayed for binding affinity at α7 and α4β2 neuronal nicotinic acetylcholine receptors (nAChRs). The investigated derivatives (3a-3c, 4a-4c, 5a-5c, 6a-6c, and 7a-7c), synthesized via the 1,3-dipolar cycloaddition of nitrile oxides to suitable dipolarophiles, showed an overall reduced affinity at the α7 subtype when compared with their model compounds. Solely Δ(2)-isoxazolines 3a, 3b, and 6c maintained a binding affinity in the nanomolar range at the α7 nAChRs (K(i) = 230, 420 and 700 nM, respectively). The quaternary ammonium salt 6c retained also a noteworthy α7 vs. α4β2 subtype selectivity, whereas 3a and 3b showed a sharp reduction in selectivity compared with 1a and 1b, their quinuclidinyl higher homologues., (Copyright © 2011 Elsevier Masson SAS. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
16. Engineering of α-conotoxin MII-derived peptides with increased selectivity for native α6β2* nicotinic acetylcholine receptors.
- Author
-
Pucci L, Grazioso G, Dallanoce C, Rizzi L, De Micheli C, Clementi F, Bertrand S, Bertrand D, Longhi R, De Amici M, and Gotti C
- Subjects
- Animals, Conotoxins genetics, Conotoxins metabolism, Male, Models, Molecular, Molecular Dynamics Simulation, Protein Binding, Protein Engineering, Rats, Rats, Sprague-Dawley, Conotoxins chemistry, Nicotinic Antagonists metabolism, Receptors, Nicotinic metabolism
- Abstract
α6β2* Nicotinic acetylcholine receptors are expressed in selected central nervous system areas, where they are involved in striatal dopamine (DA) release and its behavioral consequences, and other still uncharacterized brain activities. α6β2* receptors are selectively blocked by the α-conotoxins MII and PIA, which bear a characteristic N-terminal amino acid tail [arginine (R), aspartic acid (D), and proline (P)]. We synthesized a group of PIA-related peptides in which R1 was mutated or the RDP motif gradually removed. Binding and striatal DA release assays of native rat α6β2* receptors showed that the RDP sequence, and particularly residue R1, is essential for the activity of PIA. On the basis of molecular modeling analyses, we synthesized a hybrid peptide (RDP-MII) that had increased potency (7-fold) and affinity (13-fold) for α6β2* receptors but not for the very similar α3β2* subtype. As docking studies also suggested that E11 of MII might be a key residue engendering α6β2* vs. α3β2* selectivity, we prepared MII[E11R] and RDP-MII[E11R] peptides. Their affinity and potency for native α6β2* receptors were similar to those of their parent analogues, whereas, for the oocyte expressed rat α3β2* subtype, they showed a 31- and 14-fold lower affinity and 21- and 3.5-fold lower potency. Thus, MII[E11R] and RDP-MII[E11R] are potent antagonists showing a degree of α6β2* vs. α3β2* selectivity in vivo.
- Published
- 2011
- Full Text
- View/download PDF
17. Design, synthesis, and pharmacological characterization of novel spirocyclic quinuclidinyl-Δ2-isoxazoline derivatives as potent and selective agonists of α7 nicotinic acetylcholine receptors.
- Author
-
Dallanoce C, Magrone P, Matera C, Frigerio F, Grazioso G, De Amici M, Fucile S, Piccari V, Frydenvang K, Pucci L, Gotti C, Clementi F, and De Micheli C
- Subjects
- Animals, Aza Compounds chemistry, Aza Compounds pharmacology, Binding Sites, Catalytic Domain, Computer Simulation, Drug Design, Humans, Isoxazoles chemical synthesis, Isoxazoles pharmacology, Molecular Conformation, Nicotinic Agonists chemistry, Nicotinic Agonists pharmacology, Rats, Receptors, Nicotinic metabolism, Spiro Compounds chemical synthesis, Spiro Compounds pharmacology, Stereoisomerism, alpha7 Nicotinic Acetylcholine Receptor, Aza Compounds chemical synthesis, Isoxazoles chemistry, Nicotinic Agonists chemical synthesis, Receptors, Nicotinic chemistry, Spiro Compounds chemistry
- Abstract
A set of racemic spirocyclic quinuclidinyl-Δ(2)-isoxazoline derivatives was synthesized using a 1,3-dipolar cycloaddition-based approach. Target compounds were assayed for binding affinity toward rat neuronal homomeric (α7) and heteromeric (α4β2) nicotinic acetylcholine receptors. Δ(2) -Isoxazolines 3 a (3-Br), 6 a (3-OMe), 5 a (3-Ph), 8 a (3-OnPr), and 4 a (3-Me) were the ligands with the highest affinity for the α7 subtype (K(i) values equal to 13.5, 14.2, 25.0, 71.6, and 96.2 nM, respectively), and showed excellent α7 versus α4β2 subtype selectivity. These compounds, tested in electrophysiological experiments against human α7 and α4β2 receptors stably expressed in cell lines, behaved as partial α7 agonists with varying levels of potency. The two enantiomers of (±)-3-methoxy-1-oxa-2,7-diaza-7,10-ethanospiro[4.5]dec-2-ene sesquifumarate 6 a were prepared using (+)-dibenzoyl-L- or (-)-dibenzoyl-D-tartaric acid as resolving agents. Enantiomer (R)-(-)-6 a was found to be the eutomer, with K(i) values of 4.6 and 48.7 nM against rat and human α7 receptors, respectively., (Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2011
- Full Text
- View/download PDF
18. Expression of the α7 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS.
- Author
-
Benfante R, Antonini RA, De Pizzol M, Gotti C, Clementi F, Locati M, and Fornasari D
- Subjects
- Cell Line, Down-Regulation, Enzyme-Linked Immunosorbent Assay, Genes, Duplicate, Humans, Immunoblotting, Inflammation chemically induced, Lipopolysaccharides adverse effects, Lipopolysaccharides immunology, Monocytes metabolism, Protein Isoforms biosynthesis, Protein Isoforms genetics, Receptors, Nicotinic genetics, Reverse Transcriptase Polymerase Chain Reaction, Transcription, Genetic, alpha7 Nicotinic Acetylcholine Receptor, Gene Expression Regulation immunology, Inflammation genetics, Monocytes immunology, Receptors, Nicotinic biosynthesis
- Abstract
We investigated the expression of the partially duplicated α7 nAChR subunit gene in three monocytic cell lines: THP-1, U937 and Mono-Mac-6. Qualitative PCR revealed the presence of the classic α7 gene in these lineages, but real-time PCR showed the exclusive expression of α7dup. Both mRNA and protein levels were reduced in THP-1 upon LPS challenge, and it was found that transcriptional down-regulation was mediated by a direct mechanism dependent on NF-κB as its specific inhibitor parthenolide prevented the reduction in the α7dup transcript. Such precise regulation suggests that α7dup may specifically participate in the inflammatory response of the innate immune system., (Copyright © 2010 Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
19. Synthesis of novel chiral Δ2-isoxazoline derivatives related to ABT-418 and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.
- Author
-
Dallanoce C, Magrone P, Matera C, Lo Presti L, De Amici M, Riganti L, Clementi F, Gotti C, and De Micheli C
- Subjects
- Crystallography, X-Ray, Isoxazoles chemistry, Isoxazoles metabolism, Models, Molecular, Molecular Conformation, Neurons drug effects, Stereoisomerism, Structure-Activity Relationship, Isoxazoles chemical synthesis, Isoxazoles pharmacology, Neurons metabolism, Pyrrolidines chemistry, Receptors, Nicotinic metabolism
- Abstract
The enantiopure diastereomeric Δ2-isoxazoline derivatives (2S,5'R)-5a-10a and (2S,5'S)-5b, (2S,5'S)-9b, (2S,5'S)-11b, which are structural analogues of both ABT-418 2 and oxyimino ethers (S)-3 and (Z)-(S)-4, were synthesized through cycloaddition reactions involving nitrile oxides as 1,3-dipoles and (S)-N-Boc-2-vinylpyrrolidine-13 as the dipolarophile. The absolute configuration was unequivocally assigned to target compounds by means of an X-ray analysis. The derivatives under study were assayed at neuronal acetylcholine nicotinic receptors (nAChRs), where they showed a meaningful reduction in affinity at the heteromeric α4β2 subtype when compared to the reference molecules. Conversely, anti (2S,5'S)-5b and syn (2S,5'R)-10a isomers showed an affinity for the α7 nAChRs comparable to that observed for the model compound ABT-418., (Copyright © 2010 Elsevier Masson SAS. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
20. A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes.
- Author
-
Moretti M, Mugnaini M, Tessari M, Zoli M, Gaimarri A, Manfredi I, Pistillo F, Clementi F, and Gotti C
- Subjects
- Amino Acid Sequence, Animals, Blotting, Western, Brain metabolism, Immunoprecipitation, Infusions, Intravenous, Male, Molecular Sequence Data, Neurons metabolism, Nicotine administration & dosage, Radioligand Assay, Rats, Receptors, Nicotinic chemistry, Self Administration, Brain drug effects, Neurons drug effects, Nicotine pharmacology, Receptors, Nicotinic metabolism
- Abstract
Long-term nicotine exposure changes neuronal acetylcholine nicotinic receptor (nAChR) subtype expression in the brains of smokers and experimental animals. The aim of this study was to investigate nicotine-induced changes in nAChR expression in two models commonly used to describe the effects of nicotine in animals: operant (two-lever presses) intravenous self-administration (SA) and passive subcutaneous nicotine administration via an osmotic minipump (MP). In the MP group, alpha4beta2 nAChRs were up-regulated in all brain regions, alpha6beta2* nAChRs were down-regulated in the nucleus accumbens (NAc) and caudate-putamen, and alpha7 nAChRs were up-regulated in the caudal cerebral cortex (CCx); the up-regulation of alpha4beta2alpha5 nAChRs in the CCx was also suggested. In the SA group, alpha4beta2 up-regulation was lower and limited to the CCx and NAc; there were no detectable changes in alpha6beta2* or alpha7 nACRs. In the CCx of the MP rats, there was a close correlation between the increase in alpha4beta2 binding and alpha4 and beta2 subunit levels measured by means of Western blotting, demonstrating that the up-regulation was due to an increase in alpha4beta2 proteins. Western blotting also showed that the increase in the beta2 subunit exceeded that of the alpha4 subunit, suggesting that a change in alpha4beta2 stoichiometry may occur in vivo as has been shown in vitro. These results show that nicotine has an area-specific effect on receptor subtypes, regardless of its administration route, but the effect is quantitatively greater in the case of MP administration.
- Published
- 2010
- Full Text
- View/download PDF
21. Novel tricyclic Delta(2)-isoxazoline and 3-oxo-2-methyl-isoxazolidine derivatives: synthesis and binding affinity at neuronal nicotinic acetylcholine receptor subtypes.
- Author
-
Dallanoce C, Frigerio F, Martelli G, Grazioso G, Matera C, Pomè DY, Pucci L, Clementi F, Gotti C, and De Amici M
- Subjects
- Alkaloids chemistry, Animals, Azocines chemistry, Binding Sites, Bridged Bicyclo Compounds, Heterocyclic chemistry, Heterocyclic Compounds, 3-Ring chemical synthesis, Heterocyclic Compounds, 3-Ring pharmacology, Isoxazoles chemical synthesis, Isoxazoles pharmacology, Ligands, Models, Molecular, Protein Binding, Quinolizines chemistry, Rats, Receptors, Nicotinic metabolism, alpha7 Nicotinic Acetylcholine Receptor, Heterocyclic Compounds, 3-Ring chemistry, Isoxazoles chemistry, Neurons metabolism, Receptors, Nicotinic chemistry
- Abstract
A group of novel tricyclic Delta(2)-isoxazolines (4b, 5b, 7a-b, and 8a-b) and 3-oxo-isoxazolidines (6a-b and 9a-b), structurally related to cytisine or norferruginine, was prepared through 1,3-dipolar cycloadditions involving suitable olefins and bromonitrile oxide. The target compounds were assayed at alpha4beta2 and alpha7 neuronal acetylcholine receptors (nAChRs). The results of competition binding experiments indicated for the new derivatives a reduction of the affinity at the alpha4beta2 subtype in comparison with the reference molecules, coupled with an overall negligible affinity at the alpha7 subtype. The binding mode of the bromo-Delta(2)-isoxazolines 4b and 7b, which were the highest affinity ligands in the series (K(i)=0.92 and 0.75 microM, respectively), was analyzed by applying a recently developed model of the alpha4beta2 nAChRs., (Copyright 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
22. Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement.
- Author
-
Gotti C, Guiducci S, Tedesco V, Corbioli S, Zanetti L, Moretti M, Zanardi A, Rimondini R, Mugnaini M, Clementi F, Chiamulera C, and Zoli M
- Subjects
- Animals, Conotoxins pharmacology, Corpus Striatum drug effects, Corpus Striatum physiology, Dopamine metabolism, Feeding Behavior drug effects, Feeding Behavior physiology, Male, Mesencephalon drug effects, Mesencephalon physiology, Motor Activity drug effects, Motor Activity physiology, Neural Pathways physiology, Neurons drug effects, Neurons physiology, Nicotine administration & dosage, Nicotinic Agonists administration & dosage, Nicotinic Antagonists pharmacology, Nucleus Accumbens drug effects, Nucleus Accumbens physiology, Rats, Rats, Sprague-Dawley, Reinforcement, Psychology, Self Administration, Nicotine pharmacology, Nicotinic Agonists pharmacology, Receptors, Nicotinic metabolism, Ventral Tegmental Area drug effects, Ventral Tegmental Area physiology
- Abstract
alpha6* nicotinic acetylcholine receptors (nAChRs) are highly and selectively expressed by mesostriatal dopamine (DA) neurons. These neurons are thought to mediate several behavioral effects of nicotine, including locomotion, habit learning, and reinforcement. Yet the functional role of alpha6* nAChRs in midbrain DA neurons is mostly unknown. The aim of this study was to determine the composition and in vivo functional role of alpha6* nAChR in mesolimbic DA neurons of male rats. Immunoprecipitation and immunopurification techniques coupled with cell-specific lesions showed that the composition of alpha6* nAChR in the mesostriatal system is heterogeneous, with (non-alpha4)alpha6beta2* being predominant in the mesolimbic pathway and alpha4alpha6beta2* in the nigrostriatal pathway. We verified whether alpha6* receptors mediate the systemic effects of nicotine on the mesolimbic DA pathway by perfusing the selective antagonists alpha-conotoxin MII (CntxMII) (alpha3/alpha6beta2* selective) or alpha-conotoxin PIA (CntxPIA) (alpha6beta2* selective) into ventral tegmental area (VTA). The intra-VTA perfusion of CntxMII or CntxPIA markedly decreased systemic nicotine-elicited DA release in the nucleus accumbens and habituated locomotion; the intra-VTA perfusion of CntxMII also decreased the rate of nicotine infusion in the maintenance phase of nicotine, but not of food, self-administration. Overall, the results of these experiments show that the alpha6beta2* nAChRs expressed in the VTA are necessary for the effects of systemic nicotine on DA neuron activity and DA-dependent behaviors such as locomotion and reinforcement, and suggest that alpha6beta2*-selective compounds capable of crossing the blood-brain barrier may affect the addictive properties of nicotine and therefore be useful in the treatment of tobacco dependence.
- Published
- 2010
- Full Text
- View/download PDF
23. Structural and functional diversity of native brain neuronal nicotinic receptors.
- Author
-
Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I, Moretti M, Pedrazzi P, Pucci L, and Zoli M
- Subjects
- Animals, Humans, Neural Pathways metabolism, Nicotine pharmacology, Nicotinic Agonists pharmacology, Protein Conformation, Protein Multimerization, Protein Subunits biosynthesis, Protein Subunits chemistry, Protein Subunits physiology, Receptors, Nicotinic biosynthesis, Receptors, Nicotinic chemistry, Tobacco Use Disorder metabolism, Tobacco Use Disorder physiopathology, Brain metabolism, Neurons metabolism, Receptors, Nicotinic physiology
- Abstract
Neuronal nicotinic acetylcholine receptors (nAChRs) are a family of ligand-gated ion channels present in the central and peripheral nervous systems, that are permeable to mono- and divalent cations. They share a common basic structure but their pharmacological and functional properties arise from the wide range of different subunit combinations making up distinctive subtypes. nAChRs are involved in many physiological functions in the central and peripheral nervous systems, and are the targets of the widely used drug of abuse nicotine. In addition to tobacco dependence, changes in their number and/or function are associated with neuropsychiatric disorders, ranging from epilepsy to dementia. Although some of the neural circuits involved in the acute and chronic effects of nicotine have been identified, much less is known about which native nAChR subtypes are involved in specific physiological functions and pathophysiological conditions. We briefly review some recent findings concerning the structure and function of native nAChRs, focusing on the subtypes identified in the mesostriatal and habenulo-interpeduncular pathways, two systems involved in nicotine reinforcement and withdrawal. We also discuss recent findings concerning the effect of chronic nicotine on the expression of native subtypes.
- Published
- 2009
- Full Text
- View/download PDF
24. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
- Author
-
Tasso B, Canu Boido C, Terranova E, Gotti C, Riganti L, Clementi F, Artali R, Bombieri G, Meneghetti F, and Sparatore F
- Subjects
- Alkaloids chemistry, Alkaloids pharmacology, Animals, Azocines chemical synthesis, Azocines chemistry, Azocines metabolism, Azocines pharmacology, Cell Line, Humans, Ligands, Nicotinic Agonists chemical synthesis, Nicotinic Agonists chemistry, Nicotinic Agonists metabolism, Nicotinic Agonists pharmacology, Nicotinic Antagonists chemical synthesis, Nicotinic Antagonists chemistry, Nicotinic Antagonists metabolism, Nicotinic Antagonists pharmacology, Protein Binding, Protein Conformation, Quinolizines chemical synthesis, Quinolizines chemistry, Quinolizines metabolism, Quinolizines pharmacology, Rats, Receptors, Nicotinic chemistry, Thermodynamics, Alkaloids chemical synthesis, Alkaloids metabolism, Models, Molecular, Receptors, Nicotinic metabolism
- Abstract
The availability of drug affecting neuronal nicotinic acetylcholine receptors (nAChRs) may have important therapeutic potential for the treatment of several CNS pathologies. Pursuing our efforts on the systematic structural modification of cytisine and N-arylalkyl and N-aroylalkyl cytisines were synthesized and tested for the displacement of [(3)H]-epibatidine and [(125)I]-alpha-bungarotoxin from the most widespread brain nAChRs subtypes alpha(4)beta(2) and alpha(7), respectively. While the affinity for alpha(7) subtype was rather poor (K(i) from 0.4 to >50 microM), the affinity for alpha(4)beta(2) subtype was very interesting, with nanomolar K(i) values for the best compounds. The N-substituted cytisines were docked into the rat and human alpha(4)beta(2) nAChR models based on the extracellular domain of a molluscan acetylcholine binding protein. The docking results agreed with the binding data, allowing the detection of discrete amino acid residues of the alpha and beta subunits essential for the ligand binding on rat and human nAChRs, providing a novel structural framework for the development of new alpha(4)beta(2) selective ligands.
- Published
- 2009
- Full Text
- View/download PDF
25. Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release.
- Author
-
Grady SR, Moretti M, Zoli M, Marks MJ, Zanardi A, Pucci L, Clementi F, and Gotti C
- Subjects
- Animals, Habenula cytology, Male, Mesencephalon cytology, Mice, Mice, Knockout, Neural Pathways cytology, Neural Pathways metabolism, Protein Subunits genetics, Protein Subunits metabolism, Rats, Rats, Sprague-Dawley, Receptors, Nicotinic genetics, Synaptic Transmission genetics, Tegmentum Mesencephali, Acetylcholine metabolism, Habenula metabolism, Mesencephalon metabolism, Presynaptic Terminals metabolism, Receptors, Nicotinic metabolism
- Abstract
Recent studies suggest that the neuronal nicotinic receptors (nAChRs) present in the habenulo-interpeduncular (Hb-IPn) system can modulate the reinforcing effect of addictive drugs and the anxiolytic effect of nicotine. Hb and IPn neurons express mRNAs for most nAChR subunits, thus making it difficult to establish the subunit composition of functional receptors. We used immunoprecipitation and immunopurification studies performed in rat and wild-type (+/+) and beta2 knock-out (-/-) mice to establish that the Hb and IPn contain significant beta2* and beta4* populations of nAChR receptors (each of which is heterogeneous). The beta4* nAChR are more highly expressed in the IPn. We also identified novel native subtypes (alpha2beta2*, alpha4beta3beta2*, alpha3beta3beta4*, alpha6beta3beta4*). Our studies on IPn synaptosomes obtained from +/+ and alpha2, alpha4, alpha5, alpha6, alpha7, beta2, beta3, and beta4(-/-) mice show that only the alpha3beta4 and alpha3beta3beta4 subtypes facilitate acetylcholine (ACh) release. Ligand binding, immunoprecipitation, and Western blotting studies in beta3(-/-) mice showed that, in the IPn of these mice, there is a concomitant reduction of ACh release and alpha3beta4* receptors, whereas the receptor number remains the same in the Hb. We suggest that, in habenular cholinergic neurons, the beta3 subunit may be important for transporting the alpha3beta4* subtype from the medial habenula to the IPn. Overall, these studies highlight the presence of a wealth of uncommon nAChR subtypes in the Hb-IPn system and identify alpha3beta4 and alpha3beta3beta4, transported from the Hb and highly enriched in the IPn, as the subtypes modulating ACh release in the IPn.
- Published
- 2009
- Full Text
- View/download PDF
26. New analogues of epiboxidine incorporating the 4,5-dihydroisoxazole nucleus: synthesis, binding affinity at neuronal nicotinic acetylcholine receptors, and molecular modeling investigations.
- Author
-
Dallanoce C, Magrone P, Bazza P, Grazioso G, Rizzi L, Riganti L, Gotti C, Clementi F, Frydenvang K, and De Amici M
- Subjects
- Isoxazoles chemical synthesis, Kinetics, Models, Molecular, Protein Binding, Structure-Activity Relationship, Isoxazoles chemistry, Receptors, Nicotinic metabolism
- Abstract
A group of novel 4,5-dihydro-3-methylisoxazolyl derivatives, structurally related to epiboxidine (=(1R,4S,6S)-6-(3-methylisoxazol-5-yl)-7-azabicyclo[2.2.1]heptane), was prepared via 1,3-dipolar cycloaddition of acetonitrile oxide to different olefins. Target compounds 1a and 1b, 2a and 2b, 3, 4, and 5 were tested for affinity at neuronal nicotinic heteromeric (alpha4beta2) and homomeric (alpha7) acetylcholine receptors. Notably, diastereoisomers 1a and 1b were characterized by a massive drop of the affinity at the alpha4beta2 subtypes (K(i) values spanning the range 4.3-126 microM), when compared with that of epiboxidine (K(i)=0.6 nM). Therefore, the replacement of the 3-methylisoxazole ring of epiboxidine with the 4,5-dihydro-3-methylisoxazole nucleus is detrimental for the affinity at alpha4beta2 receptors. A comparable lack of affinity/selectivity for the two nAChR subtypes under study was evidenced for the remaining epiboxidine-related dihydroisoxazole derivatives 2a and 2b, and 3-5. Diastereoisomers 1a and 1b, and spirocyclic derivative 3 were docked into molecular models of the receptor subtypes under study, and their binding mode was compared with that of reference ligands endowed with high binding affinity.
- Published
- 2009
- Full Text
- View/download PDF
27. 5-(2-Pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: synthesis of all the stereoisomers and alpha4beta2 nicotinic affinity.
- Author
-
Pallavicini M, Bolchi C, Binda M, Cilia A, Clementi F, Ferrara R, Fumagalli L, Gotti C, Moretti M, Pedretti A, Vistoli G, and Valoti E
- Subjects
- Acetylcholine chemistry, Animals, Binding Sites, Brain metabolism, Carbon chemistry, Dioxanes pharmacology, Hydrogen Bonding, Kinetics, Ligands, Models, Chemical, Oxazolidinones pharmacology, Rats, Receptors, Nicotinic metabolism, Stereoisomerism, Dioxanes chemical synthesis, Oxazolidinones chemical synthesis, Pyrrolidines chemical synthesis, Receptors, Nicotinic chemistry
- Abstract
The four stereoisomers of 2-oxazolidinone 5-substituted with 1-methyl-2-pyrrolidinyl (1), of 1,4-benzodioxane 2-substituted with the same residue (2) and of the nor-methyl analogue of this latter (2a) were synthesized as candidate nicotinoids. Of the 12 compounds, two N-methylated pyrrolidinyl-benzodioxane stereoisomers, namely those with the same relative configuration at the pyrrolidine stereocentre as (S)-nicotine, bind at alpha4beta2 nicotinic acetylcholine receptor with submicromolar affinity. Consistently with the biological data, docking analysis enlightens significant differences in binding site interactions not only between 1 and 2, but also between 2 and 2a and between the stereoisomers of 2 accounting for the critical role played, in the case of the pyrrolidinyl-benzodioxanes, by the chirality of both the stereolabile and stereostable stereogenic atoms, namely the protonated tertiary nitrogen and the two asymmetric carbons.
- Published
- 2009
- Full Text
- View/download PDF
28. Epiboxidine and novel-related analogues: a convenient synthetic approach and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.
- Author
-
Rizzi L, Dallanoce C, Matera C, Magrone P, Pucci L, Gotti C, Clementi F, and De Amici M
- Subjects
- Animals, Binding, Competitive, Catalysis, Cerebral Cortex drug effects, Chemistry, Pharmaceutical, Drug Design, Isoxazoles chemistry, Kinetics, Ligands, Models, Chemical, Neurons metabolism, Rats, Receptors, Nicotinic chemistry, Structure-Activity Relationship, Temperature, Isoxazoles chemical synthesis, Isoxazoles pharmacology, Receptors, Nicotinic drug effects
- Abstract
Racemic exo-epiboxidine 3, endo-epiboxidine 6, and the two unsaturated epiboxidine-related derivatives 7 and 8 were efficiently prepared taking advantage of a palladium-catalyzed Stille coupling as the key step in the reaction sequence. The target compounds were assayed for their binding affinity at neuronal alpha4beta2 and alpha7 nicotinic acetylcholine receptors. Epiboxidine 3 behaved as a high affinity alpha4beta2 ligand (K(i)=0.4 nM) and, interestingly, evidenced a relevant affinity also for the alpha7 subtype (K(i)=6 nM). Derivative 7, the closest analogue of 3 in this group, bound with lower affinity at both receptor subtypes (K(i)=50 nM for alpha4beta2 and K(i)=1.6 microM for alpha7) evidenced a gain in the alpha4beta2 versus alpha7 selectivity when compared with the model compound.
- Published
- 2008
- Full Text
- View/download PDF
29. Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.
- Author
-
Gotti C, Moretti M, Meinerz NM, Clementi F, Gaimarri A, Collins AC, and Marks MJ
- Subjects
- Acetylcholine pharmacology, Animals, Cerebral Cortex drug effects, Gene Expression Regulation drug effects, Gene Expression Regulation physiology, Mice, Mice, Inbred C57BL, Protein Subunits antagonists & inhibitors, Protein Subunits biosynthesis, Protein Subunits genetics, Receptors, Nicotinic metabolism, Rubidium Radioisotopes metabolism, Thalamus drug effects, Acetylcholine metabolism, Cerebral Cortex metabolism, Gene Deletion, Receptors, Nicotinic biosynthesis, Receptors, Nicotinic genetics, Thalamus metabolism
- Abstract
Alpha4 and beta2 nicotinic cholinergic receptor (nAChR) subunits can assemble in heterologous expression systems as pentameric receptors with different subunit stoichiometries that exhibit differential sensitivity to activation by acetylcholine, yielding biphasic concentration-effect curves. nAChR-mediated (86)Rb(+) efflux in mouse brain synaptosomes also displays biphasic acetylcholine (ACh) concentration-response curves. Both phases are mediated primarily by alpha4beta2(*)-nAChR, because deletion of either the alpha4 or beta2 subunit reduces response at least 90%. A relatively larger decrease in the component of (86)Rb(+) efflux with lower ACh sensitivity occurred with partial deletion of alpha4 (alpha4(+/-)), whereas a larger decrease in the component with higher ACh sensitivity was elicited by partial deletion of beta2 (beta2(+/-)). Immunoprecipitation with selective antibodies demonstrated that more than 70% of [(3)H]epibatidine binding sites in both regions contained only alpha4 and beta2 subunits. Subsequently, alpha4 and beta2 subunit content in the cortex and thalamus of alpha4 and beta2 wild types and heterozygotes was analyzed with Western blots. Partial deletion of alpha4 decreased and partial deletion of beta2 increased the relative proportion of the alpha4 subunit in assembled receptors. Although these methods do not allow exact identification of stoichiometry of the subtypes present in wild-type cortex and thalamus, they do demonstrate that cortical and thalamic nAChRs of the alpha4(+/-) and beta2(+/-) genotypes differ in relative expression of alpha4 and beta2 subunits a result that corresponds to the relative functional changes observed after partial gene deletion. These results strongly suggest that alpha4beta2-nAChR with different stoichiometry are expressed in native tissue.
- Published
- 2008
- Full Text
- View/download PDF
30. Regulation of neuronal nicotinic receptor traffic and expression.
- Author
-
Gaimarri A, Moretti M, Riganti L, Zanardi A, Clementi F, and Gotti C
- Subjects
- Animals, Brain cytology, Gene Expression Regulation drug effects, Nicotinic Antagonists pharmacology, Protein Transport drug effects, Protein Transport physiology, Receptors, Nicotinic chemistry, Receptors, Nicotinic genetics, Gene Expression Regulation physiology, Neurons metabolism, Receptors, Nicotinic metabolism
- Abstract
Neuronal nicotinic acetylcholine receptors (nAChRs) are a family of cation channels widely distributed in the brain, whose subunit composition and biophysical properties vary depending on the subtype and the area of the brain in which they are found. Brain nAChRs are also the target of nicotine, the most widespread drug of abuse. Chronic nicotine exposure differentially affects the number, subunit composition, stoichiometry and functional state of some nAChR subtypes, leaving others substantially unaffected. In this review, we will summarise recent data concerning the nAChR subtypes expressed in the CNS, and how they are regulated by means of chronic nicotine and/or nicotinic drugs. We will particularly focus on the possible mechanisms involved in the up-regulation of nAChRs.
- Published
- 2007
- Full Text
- View/download PDF
31. Transcription factor PHOX2A regulates the human alpha3 nicotinic receptor subunit gene promoter.
- Author
-
Benfante R, Flora A, Di Lascio S, Cargnin F, Longhi R, Colombo S, Clementi F, and Fornasari D
- Subjects
- Cell Differentiation physiology, Cell Line, Tumor, Chromatin Immunoprecipitation, Homeodomain Proteins genetics, Humans, Protein Binding genetics, Receptors, Nicotinic genetics, Sp1 Transcription Factor genetics, Sp1 Transcription Factor metabolism, Gene Expression Regulation physiology, Homeodomain Proteins metabolism, Nerve Tissue metabolism, Receptors, Nicotinic biosynthesis, Response Elements physiology, Transcription, Genetic physiology
- Abstract
PHOX2A is a paired-like homeodomain transcription factor that participates in specifying the autonomic nervous system. It is also involved in the transcriptional control of the noradrenergic neurotransmitter phenotype as it regulates the gene expression of tyrosine hydroxylase and dopamine-beta-hydroxylase. The results of this study show that the human orthologue of PHOX2A is also capable of regulating the transcription of the human alpha3 nicotinic acetylcholine receptor gene, which encodes the ligand-binding subunit of the ganglionic type nicotinic receptor. In particular, we demonstrated by chromatin immunoprecipitation and DNA pulldown assays that PHOX2A assembles on the SacI-NcoI region of alpha3 promoter and, by co-transfection experiments, that it exerts its transcriptional effects by acting through the 60-bp minimal promoter. PHOX2A does not seem to bind to DNA directly, and its DNA binding domain seems to be partially dispensable for the regulation of alpha3 gene transcription. However, as suggested by the findings of our co-immunoprecipitation assays, it may establish direct or indirect protein-protein interactions with Sp1, thus regulating the expression of alpha3 through a DNA-independent mechanism. As the alpha3 subunit is expressed in every terminally differentiated ganglionic cell, this is the first example of a "pan-autonomic" gene whose expression is regulated by PHOX2 proteins.
- Published
- 2007
- Full Text
- View/download PDF
32. Synthesis and alpha4beta2 nicotinic affinity of unichiral 5-(2-pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes.
- Author
-
Pallavicini M, Moroni B, Bolchi C, Cilia A, Clementi F, Fumagalli L, Gotti C, Meneghetti F, Riganti L, Vistoli G, and Valoti E
- Subjects
- Protein Binding, Dioxanes chemical synthesis, Dioxanes metabolism, Oxazolidinones chemical synthesis, Oxazolidinones metabolism, Receptors, Nicotinic metabolism
- Abstract
The RS and SR enantiomers of 2-oxazolidinone and 1,4-benzodioxane bearing a 2-pyrrolidinyl substituent at the 5- and 2-position, respectively, were synthesized as candidate nicotinoids. One of the two benzodioxane stereoisomers reasonably fits the pharmacophore elements of (S)-nicotine and binds at alpha4beta2 nicotinic acetylcholine receptor with submicromolar affinity. Interestingly, both the synthesized pyrrolidinylbenzodioxanes exhibit analogous affinity at alpha(2) adrenergic receptor resembling the behaviour of some known alpha(2)-AR ligands recently proved to possess neuronal nicotinic affinity.
- Published
- 2006
- Full Text
- View/download PDF
33. Brain nicotinic acetylcholine receptors: native subtypes and their relevance.
- Author
-
Gotti C, Zoli M, and Clementi F
- Subjects
- Animals, Binding Sites, Humans, Ligands, Protein Subunits, Receptors, Nicotinic chemistry, Receptors, Nicotinic drug effects, Receptors, Nicotinic physiology, Brain metabolism, Receptors, Nicotinic classification
- Abstract
Neuronal nicotinic acetylcholine receptors comprise a heterogeneous class of cationic channels that is present throughout the nervous system. These channels are involved both in physiological functions (including cognition, reward, motor activity and analgesia) and in pathological conditions such as Alzheimer's disease, Parkinson's disease, some forms of epilepsy, depression, autism and schizophrenia. They are also the targets of tobacco-smoking effects and addiction. Neuronal nicotinic acetylcholine receptors are pentamers of homomeric or heteromeric combinations of alpha (alpha2-alpha10) and beta (beta2-beta4) subunits, which have different pharmacological and biophysical properties and locations in the brain. The lack of subtype-specific ligands and the fact that many neuronal cells express multiple subtypes initially hampered the identification of the different native nicotinic acetylcholine receptor subtypes, but the increasing knowledge of subtype composition and roles will be of considerable interest for the development of new and clinically useful nicotinic acetylcholine receptor ligands.
- Published
- 2006
- Full Text
- View/download PDF
34. Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.
- Author
-
Gotti C, Moretti M, Bohr I, Ziabreva I, Vailati S, Longhi R, Riganti L, Gaimarri A, McKeith IG, Perry RH, Aarsland D, Larsen JP, Sher E, Beattie R, Clementi F, and Court JA
- Subjects
- Aged, Aged, 80 and over, Amino Acid Sequence, Autopsy, Female, Humans, Male, Molecular Sequence Data, Peptide Fragments immunology, Receptors, Nicotinic chemistry, Receptors, Nicotinic genetics, Alzheimer Disease pathology, Corpus Striatum pathology, Lewy Bodies pathology, Parkinson Disease pathology, Receptors, Nicotinic deficiency, Temporal Lobe pathology
- Abstract
Antibodies raised against human alpha2-6 and beta2-4 nicotinic receptor subunits were utilized to fractionate (3)H-epibatidine binding in human temporal cortex and striatum. The predominant receptor subtypes in both regions contained alpha4 and beta2 subunits. In normal cortex, 10% of binding was also associated with alpha2 subunits, whereas in the striatum, contributions by alpha6 (17%) and beta3 (23%) were observed. Minimal binding (< or =5%) was associated with alpha3. In Alzheimer's disease and dementia with Lewy bodies, cortical loss of binding was associated with reductions in alpha4 (50%, P < 0.01) and beta2 (30-38%, P < 0.05). In Parkinson's disease and dementia with Lewy bodies, striatal deficits in alpha6 (91 and 59% respectively, P < 0.01) and beta3 (72 and 75%, P < 0.05) tended to be greater than for alpha4 and beta2 (50-58%, P < 0.05). This study demonstrates distinct combinations of subunits contributing to heteromeric nicotinic receptor binding in the human brain that are area/pathway specific and differentially affected by neurodegeneration.
- Published
- 2006
- Full Text
- View/download PDF
35. Extremely low-frequency electromagnetic field (ELF-EMF) does not affect the expression of alpha3, alpha5 and alpha7 nicotinic receptor subunit genes in SH-SY5Y neuroblastoma cell line.
- Author
-
Antonini RA, Benfante R, Gotti C, Moretti M, Kuster N, Schuderer J, Clementi F, and Fornasari D
- Subjects
- Blotting, Northern, Bridged Bicyclo Compounds, Heterocyclic pharmacology, Bungarotoxins pharmacology, Cell Line, Tumor, Humans, Nerve Tissue Proteins metabolism, Neuroblastoma pathology, Pyridines pharmacology, RNA, Messenger genetics, Radioligand Assay, Receptors, Nicotinic metabolism, alpha7 Nicotinic Acetylcholine Receptor, Electromagnetic Fields adverse effects, Gene Expression radiation effects, Nerve Tissue Proteins genetics, Receptors, Nicotinic genetics
- Abstract
Neuronal nicotinic acetylcholine receptors (nAChRs) are involved in a number of functional processes, including cognition, learning and memory, and alterations in their expression and/or activity have been implicated in various neurological disorders such as Alzheimer's disease (AD), Parkinson's disease and schizophrenia. Epidemiological studies have shown that exposure to electromagnetic fields (EMF) may contribute to the pathogenesis of neurodegenerative diseases such as Alzheimer's disease. Given the role of nAChRs in physiological and pathological conditions, we wondered whether an extremely low-frequency electromagnetic field (ELF-EMF) may affect the expression of the molecules involved in neurodegenerative processes. In order to investigate this possibility, we studied the expression of alpha3, alpha5 and alpha7 nicotinic subunits upon exposure of the SH-SY5Y human neuroblastoma cell line to a 50 Hz power-line magnetic field in a "blind trial" system; various magnetic flux densities and exposure times were applied. Our studies show that the expression of some relevant components of the cholinergic nicotinic system, which is one of the most affected neurotransmission systems in AD, did not undergo any change at molecular level by environmental exposure to ELF-EMF.
- Published
- 2006
- Full Text
- View/download PDF
36. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
- Author
-
Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, and Gotti C
- Subjects
- Alkaloids pharmacology, Binding Sites, Bridged Bicyclo Compounds, Heterocyclic pharmacology, Bungarotoxins pharmacology, Cell Line, Tumor, Cell Membrane drug effects, Cell Membrane metabolism, Dose-Response Relationship, Drug, Humans, Inhibitory Concentration 50, Membrane Potentials drug effects, Nerve Tissue Proteins drug effects, Neuroblastoma, Neurons metabolism, Neurons ultrastructure, Nicotine pharmacology, Nicotinic Agonists pharmacology, Protein Structure, Quaternary drug effects, Protein Transport drug effects, Pyridines pharmacology, Receptors, Nicotinic drug effects, Subcellular Fractions drug effects, Subcellular Fractions metabolism, Time Factors, Up-Regulation, alpha7 Nicotinic Acetylcholine Receptor, Azocines pharmacology, Nerve Tissue Proteins metabolism, Neurons drug effects, Nicotinic Antagonists pharmacology, Quinolizines pharmacology, Receptors, Nicotinic metabolism
- Abstract
Nicotinic drug treatment can affect the expression of neuronal nicotinic acetylcholine receptors (nAChR) both in vivo and in vitro through molecular mechanisms not fully understood. The present study investigated the effect of the novel cytisine dimer 1,2-bisN-cytisinylethane (CC4) on nAChR natively expressed by SH-SY5Y neuroblastoma cells in culture. CC4 lacked the agonist properties of cytisine and was a potent antagonist (IC50=220 nM) on nAChRs. Chronic treatment of SH-SY5Y cells with 1 mM CC4 for 48 h increased the expression of 3H-epibatidine (3H-Epi; 3-4-fold) or 125I-alpha-bungarotoxin (125I-alphaBgtx; 1.2-fold) sensitive receptors present on the cell membrane and in the intracellular pool. Comparable data were obtained with nicotine or cytisine, but not with carbamylcholine, d-tubocurarine, di-hydro-beta-erythroidine or hexametonium. Immunoprecipitation and immunopurification studies showed that the increase in 3H-Epi-binding receptors was due to the enhanced expression of alpha3beta2 and alpha3beta2beta4 subtypes without changes in subunit mRNA transcription or receptor half-life. The upregulation was not dependent on agonist/antagonist properties of the drugs, and did not concern muscarinic or serotonin receptors. Whole-cell patch clamp analysis of CC4-treated cells demonstrated larger nicotine-evoked inward currents with augmented sensitivity to the blockers alpha-conotoxin MII or methyllycaconitine. In conclusion, chronic treatment with CC4 increased the number of nAChRs containing beta2 and alpha7 subunits on the plasma membrane, where they were functionally active. In the case of beta2-containing receptors, we propose that CC4, by binding to intracellular receptors, triggered a conformational reorganisation of intracellular subunits that stimulated preferential assembly and membrane-directed trafficking of beta2-containing receptor subtypes..
- Published
- 2005
- Full Text
- View/download PDF
37. Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus: identification of a new native nAChR subtype alpha3beta2(alpha5 or beta3) enriched in retinocollicular afferents.
- Author
-
Gotti C, Moretti M, Zanardi A, Gaimarri A, Champtiaux N, Changeux JP, Whiteaker P, Marks MJ, Clementi F, and Zoli M
- Subjects
- Amino Acid Sequence, Animals, Immunoprecipitation, Ligands, Male, Molecular Sequence Data, Protein Binding, Rats, Rats, Sprague-Dawley, Receptors, Nicotinic classification, Retina metabolism, Geniculate Bodies metabolism, Neurons, Afferent metabolism, Receptors, Nicotinic metabolism, Superior Colliculi metabolism
- Abstract
The activation of neuronal nicotinic acetylcholine receptors (nAChRs) has been implicated in the activity-dependent development and plasticity of retina and the refinement of retinal projections. Pharmacological and functional studies have also indicated that different presynaptic nAChRs can have a modulatory function in retinotectal synapses. We biochemically and pharmacologically identified the multiple nAChR subtypes expressed on retinal afferents of the superior colliculus (SC) and lateral geniculate nucleus (LGN). We found that the alpha6beta2(*) and alpha4(nonalpha6)beta2(*) nAChRs are the major receptor populations expressed in both SC and LGN. In addition, the LGN contains two minor populations of alpha2alpha6beta2(*) and alpha3beta2(*) subtypes, whereas the SC contains a relatively large population of a new native subtype, the alpha3beta2(alpha5/beta3) nAChR. This subtype binds the alpha-conotoxin MII with an affinity 50 times lower than that of the native alpha6beta2(*) subtype. Studies of tissues obtained from eye-enucleated animals allowed the identification of nAChRs expressed by retinal afferents: in SC alpha6beta2(*), alpha4alpha6beta2(*), and alpha3beta2(*) (approximately 45, 35, and 20%, respectively), in LGN, alpha4alpha6beta2(*), alpha6beta2(*), alpha4beta2(*), alpha2alpha6beta2(*), and alpha3beta2(*) (approximately 40, 30, 20, 5, and 5%, respectively). In both regions, more than 50% of nAChRs were not expressed by retinal afferents and belonged to the alpha4beta2(*) (90%) or alpha4alpha5beta2(*) (10%) subtypes. Moreover, studies of the SC tissues obtained from wild-type and alpha4, alpha6, and beta3 knockout mice confirmed and extended the data obtained in rat tissue and allowed a comprehensive dissection of the composition of nAChR subtypes present in this retinorecipient area.
- Published
- 2005
- Full Text
- View/download PDF
38. Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.
- Author
-
Gotti C, Moretti M, Clementi F, Riganti L, McIntosh JM, Collins AC, Marks MJ, and Whiteaker P
- Subjects
- Amino Acid Sequence, Animals, Gene Expression Regulation physiology, Humans, Mice, Mice, Inbred C57BL, Mice, Knockout, Molecular Sequence Data, Protein Subunits genetics, Rats, Receptors, Nicotinic genetics, Corpus Striatum metabolism, Gene Deletion, Protein Subunits deficiency, Receptors, Nicotinic biosynthesis, Receptors, Nicotinic deficiency, Substantia Nigra metabolism
- Abstract
mRNAs for the neuronal nicotinic acetylcholine receptor (nAChR) alpha6 and beta3 subunits are abundantly expressed and colocalized in dopaminergic cells of the substantia nigra and ventral tegmental area. Studies using subunit-null mutant mice have shown that alpha6- or beta3-dependent nAChRs bind alpha-conotoxin MII (alpha-CtxMII) with high affinity and modulate striatal dopamine release. This study explores the effects of beta3 subunit-null mutation on striatal and midbrain nAChR expression, composition, and pharmacology. Ligand binding and immunoprecipitation experiments using subunit-specific antibodies indicated that beta3-null mutation selectively reduced striatal alpha6* nAChR expression by 76% versus beta3(+/+) control. Parallel experiments showed a smaller reduction in both midbrain alpha3* and alpha6* nAChRs (34 and 42% versus beta3(+/+) control, respectively). Sedimentation coefficient determinations indicated that residual alpha6* nAChRs in beta3(-/-) striatum were pentameric, like their wild-type counterparts. Immunoprecipitation experiments on immunopurified beta3* nAChRs demonstrated that almost all wild-type striatal beta3* nAChRs also contain alpha4, alpha6, and beta2 subunits, although a small population of non-beta3 alpha6* nAChRs is also expressed. beta3 subunit incorporation seemed to increase alpha4 participation in alpha6beta2* complexes. (125)I-Epibatidine competition binding studies showed that the alpha-CtxMII affinity of alpha6* nAChRs from the striata of beta3(-/-) mice was similar to those isolated from beta3(+/+) animals. Together, the results of these experiments show that the beta3 subunit is important for the correct assembly, stability and/or transport of alpha6* nAChRs in dopaminergic neurons and influences their subunit composition. However, beta3 subunit expression is not essential for the expression of alpha6*, high-affinity alpha-CtxMII binding nAChRs.
- Published
- 2005
- Full Text
- View/download PDF
39. Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA.
- Author
-
Quik M, Vailati S, Bordia T, Kulak JM, Fan H, McIntosh JM, Clementi F, and Gotti C
- Subjects
- Alkaloids pharmacokinetics, Amino Acid Sequence, Animals, Antibodies, Autoradiography, Azocines pharmacokinetics, Brain physiology, Bridged Bicyclo Compounds, Heterocyclic pharmacokinetics, Cell Membrane drug effects, Cell Membrane physiology, Cerebral Cortex drug effects, Cerebral Cortex physiology, Corpus Striatum drug effects, Corpus Striatum physiology, Humans, Iodine Radioisotopes, Molecular Sequence Data, Nicotine antagonists & inhibitors, Nicotine pharmacokinetics, Protein Subunits chemistry, Pyridines pharmacokinetics, Quinolizines pharmacokinetics, Receptors, Nicotinic chemistry, Saimiri, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine pharmacology, Levodopa pharmacology, Receptors, Nicotinic drug effects, Receptors, Nicotinic physiology
- Abstract
Nicotinic acetylcholine receptors (nAChRs) represent an important modulator of striatal function both under normal conditions and in pathological states such as Parkinson's disease. Because different nAChR subtypes may have unique functions, immunoprecipitation and ligand binding studies were done to identify their subunit composition. As in the rodent, alpha2, alpha4, alpha6, beta2, and beta3 nAChR subunit immunoreactivity was identified in monkey striatum. However, distinct from the rodent, the present results also revealed the novel presence of alpha3 nAChR subunit-immunoreactivity in this same region, but not that for alpha5 and beta4. Relatively high levels of alpha2 and alpha3 subunits were also identified in monkey cortex, in addition to alpha4 and beta2. Experiments were next done to determine whether striatal subunit expression was changed with nigrostriatal damage. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment decreased alpha6 and beta3 subunit immunoreactivity by approximately 80% in parallel with the dopamine transporter, suggesting that they are predominantly expressed on nigrostriatal dopaminergic projections. In contrast, alpha3, alpha4, and beta2 subunit immunoreactivity was decreased approximately 50%, whereas alpha2 was not changed. These data, together with those from dual immunoprecipitation and radioligand binding studies ([(3)H]cytisine, (125)I-alpha-bungarotoxin, and (125)I-alpha-conotoxin MII) suggest the following: that alpha6beta2beta3, alpha6alpha4beta2beta3, and alpha3beta2* nAChR subtypes are present on dopaminergic terminals and that the alpha4beta2 subtype is localized on both dopaminergic and nondopaminergic neurons, whereas alpha2beta2* and alpha7 receptors are localized on nondopaminergic cells in monkey striatum. Overall, these results suggest that drugs targeting non-alpha7 nicotinic receptors may be useful in the treatment of disorders characterized by nigrostriatal dopaminergic damage, such as Parkinson's disease.
- Published
- 2005
- Full Text
- View/download PDF
40. Synthesis and alpha4beta2 nicotinic affinity of 2-pyrrolidinylmethoxyimines and prolinal oxime ethers.
- Author
-
Pallavicini M, Moroni B, Bolchi C, Clementi F, Fumagalli L, Gotti C, Vailati S, Valoti E, and Villa L
- Subjects
- Animals, Cerebral Cortex metabolism, Imines metabolism, Proline metabolism, Protein Binding physiology, Pyrrolidines metabolism, Rats, Imines chemical synthesis, Proline analogs & derivatives, Proline chemical synthesis, Pyrrolidines chemical synthesis, Receptors, Nicotinic metabolism
- Abstract
Homochiral E and Z isomers of N-methylprolinal O-isopropyloxime and (1-methyl-2-pyrrolidinyl)methoxyimines were synthesized as candidate bioisosteres of nicotine and its isoxazolic analogue ABT 418. Two of them, namely (S)-2-isopropylideneaminooxymethyl- and (Z)-(S)-2-ethylideneaminooxymethyl-1-methylpyrrolidine, proved to bind at alpha4beta2 nicotinic acetylcholine receptor with submicromolar affinity and remarkable selectivity over alpha7 and muscarinic receptors thus supporting the hypothesized bioisosteric relationship between their methyloxyimino group and the aromatic heterocycles of the reference ligands.
- Published
- 2004
- Full Text
- View/download PDF
41. Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience.
- Author
-
Moretti M, Vailati S, Zoli M, Lippi G, Riganti L, Longhi R, Viegi A, Clementi F, and Gotti C
- Subjects
- Animals, Blotting, Western, Bridged Bicyclo Compounds, Heterocyclic pharmacology, Bungarotoxins pharmacology, Iodine Radioisotopes, Male, Nicotinic Agonists pharmacology, Protein Subunits classification, Protein Subunits drug effects, Protein Subunits genetics, Pyridines pharmacology, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Receptors, Nicotinic classification, Receptors, Nicotinic drug effects, Receptors, Nicotinic genetics, Retina drug effects, Retina growth & development, Tritium, Protein Subunits metabolism, Receptors, Nicotinic metabolism, Retina metabolism
- Abstract
By acting through retinal nicotinic acetylcholine receptors (nAChRs), acetylcholine plays an important role in the development of both the retina and central visual pathways. Ligand binding and immunoprecipitation studies with subunit-specific antibodies showed that the expression of alphaBungarotoxin (alphaBgtx) and high-affinity epibatidine (Epi) receptors is regulated developmentally and increases until postnatal day 21 (P21). The increase in Epi receptors is caused by a selective increase in the subtypes containing the alpha2, alpha4, alpha6, beta2, and beta3 subunits. Immunopurification studies revealed three major populations of Epi receptors on P21: alpha6(*) receptors (26%), which contain the alpha6beta3beta2, alpha6alpha4beta3beta2, and alpha6alpha3/alpha2beta3beta2 subtypes; alpha4(non-alpha6)(*) receptors (60%), which contain the alpha2alpha4beta2 and alpha4beta2 subtypes; and (non-alpha4/non-alpha6)(*) receptors (14%), which contain the alpha2beta2/beta4 and alpha3beta2/beta4 subtypes. These three populations can be pharmacologically discriminated using alphaconotoxin MII, which binds the alpha6(*) population with high affinity. In situ hybridization showed that the transcripts for all of the subunits are heterogeneously distributed throughout retinal neurons at P21, with alpha3, alpha6, and beta3 transcripts preferentially concentrated in the ganglion cell layer, alpha5 in the inner nuclear layer, and alpha4 and beta2 distributed rather homogeneously. To investigate whether nAChR expression is affected by visual experience, we also studied dark-reared P21 rats. Visual deprivation had no effect on the expression of alphaBgtx receptors or the developmentally regulated Epi receptors containing the alpha2, alpha6, and/or beta3 subunits but significantly increased the expression of the Epi receptors containing the alpha4 and beta2 subunits. Overall, this study demonstrates that the retina is the rat neural region that expresses the widest array of nAChR subtypes. These receptors have a specific distribution, and their expression is finely regulated during development and by visual experience.
- Published
- 2004
- Full Text
- View/download PDF
42. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice.
- Author
-
Champtiaux N, Gotti C, Cordero-Erausquin M, David DJ, Przybylski C, Léna C, Clementi F, Moretti M, Rossi FM, Le Novère N, McIntosh JM, Gardier AM, and Changeux JP
- Subjects
- Acetylcholine pharmacology, Animals, Cells, Cultured, Electric Conductivity, Mice, Mice, Knockout, Neostriatum chemistry, Neurons drug effects, Nicotine pharmacology, Nicotinic Agonists metabolism, Nicotinic Antagonists metabolism, Nucleus Accumbens metabolism, Patch-Clamp Techniques, Protein Subunits, Receptors, Nicotinic analysis, Receptors, Nicotinic genetics, Receptors, Nicotinic immunology, Receptors, Nicotinic metabolism, Substantia Nigra cytology, Substantia Nigra physiology, Synaptosomes drug effects, Synaptosomes metabolism, Ventral Tegmental Area cytology, Ventral Tegmental Area physiology, Dopamine metabolism, Mesencephalon physiology, Neostriatum metabolism, Neurons physiology, Receptors, Nicotinic physiology
- Abstract
Nicotinic acetylcholine receptors (nAChRs) expressed by dopaminergic (DA) neurons have long been considered as potential therapeutic targets for the treatment of several neuropsychiatric diseases, including nicotine and cocaine addiction or Parkinson's disease. However, DA neurons express mRNAs coding for most, if not all, neuronal nAChR subunits, and the subunit composition of functional nAChRs has been difficult to establish. Immunoprecipitation experiments performed on mouse striatal extracts allowed us to identify three main types of heteromeric nAChRs (alpha4beta2*, alpha6beta2*, and alpha4alpha6beta2*) in DA terminal fields. The functional relevance of these subtypes was then examined by studying nicotine-induced DA release in striatal synaptosomes and recording ACh-elicited currents in DA neurons fromalpha4, alpha6, alpha4alpha6, and beta2 knock-out mice. Our results establish that alpha6beta2* nAChRs are functional and sensitive to alpha-conotoxin MII inhibition. These receptors are mainly located on DA terminals and consistently do not contribute to DA release induced by systemic nicotine administration, as evidenced by in vivo microdialysis. In contrast, (nonalpha6)alpha4beta2* nAChRs represent the majority of functional heteromeric nAChRs on DA neuronal soma. Thus, whereas a combination of alpha6beta2* and alpha4beta2* nAChRs may mediate the endogenous cholinergic modulation of DA release at the terminal level, somato-dendritic (nonalpha6)alpha4beta2* nAChRs most likely contribute to nicotine reinforcement.
- Published
- 2003
43. Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes.
- Author
-
Carbonnelle E, Sparatore F, Canu-Boido C, Salvagno C, Baldani-Guerra B, Terstappen G, Zwart R, Vijverberg H, Clementi F, and Gotti C
- Subjects
- Alkaloids agonists, Animals, Azocines agonists, Binding, Competitive, Bridged Bicyclo Compounds, Heterocyclic metabolism, Bridged Bicyclo Compounds, Heterocyclic pharmacokinetics, Bungarotoxins metabolism, Bungarotoxins pharmacokinetics, Calcium chemistry, Calcium metabolism, Cell Line, Female, Gene Expression, Iodine Radioisotopes, Molecular Structure, Neurons metabolism, Nicotinic Agonists chemical synthesis, Nicotinic Agonists pharmacokinetics, Nicotinic Antagonists chemical synthesis, Nicotinic Antagonists pharmacokinetics, Oocytes drug effects, Pyridines metabolism, Pyridines pharmacokinetics, Quinolizines agonists, Radioligand Assay, Rats, Receptors, Nicotinic genetics, Receptors, Nicotinic metabolism, Structure-Activity Relationship, Tritium, Xenopus laevis, Alkaloids chemical synthesis, Alkaloids pharmacology, Azocines chemical synthesis, Azocines pharmacology, Neurons drug effects, Nitrogen analysis, Quinolizines chemical synthesis, Quinolizines pharmacology, Receptors, Nicotinic drug effects
- Abstract
Cytisine very potently binds and activates the alpha 3 beta 4 and alpha 7 nicotinic subtypes, but only partially agonises the alpha 4 beta 2 subtype. Although with a lower affinity than cytisine, new cytisine derivatives with different substituents on the basic nitrogen (CC1-CC8) bind to both the heteromeric and homomeric subtypes, with higher affinity for brain [3H]epibatidine receptors. The cytisine derivatives were tested on the Ca(2+) flux of native or transfected cell lines expressing the rat alpha 7, or human alpha 3 beta 4 or alpha 4 beta 2 subtypes using Ca(2+) dynamics in conjunction with a fluorescent image plate reader. None elicited any response at doses of up to 30-100 microM, but all inhibited agonist-induced responses. Compounds CC5 and CC7 were also electrophysiologically tested on oocyte-expressed rat alpha 4 beta 2, alpha 3 beta 4 and alpha 7 subtypes. CC5 competitively antagonised the alpha 4 beta 2 and alpha 3 beta 4 subtypes with similar potency, whereas CC7 only partially agonised them with maximum responses of respectively 3% and 11% of those of 1 mM acetylcholine. Neither compound induced any current in the oocyte-expressed alpha 7 subtype, and both weakly inhibited acetylcholine-induced currents. Adding chemical groups of a different class or size to the basic nitrogen of cytisine leads to compounds that lose full agonist activity on the alpha 3 beta 4 and alpha 7 subtypes.
- Published
- 2003
- Full Text
- View/download PDF
44. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum.
- Author
-
Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, and Gotti C
- Subjects
- Animals, Binding, Competitive drug effects, Corpus Striatum cytology, Corpus Striatum drug effects, Dopamine Uptake Inhibitors pharmacology, Ligands, Male, Nicotinic Agonists pharmacokinetics, Nicotinic Antagonists pharmacokinetics, Oxidopamine, Precipitin Tests, Rats, Rats, Sprague-Dawley, Receptors, Nicotinic analysis, Receptors, Nicotinic classification, Specific Pathogen-Free Organisms, Corpus Striatum metabolism, Dopamine metabolism, Presynaptic Terminals metabolism, Protein Subunits, Receptors, Nicotinic biosynthesis
- Abstract
Neuronal nicotinic acetylcholine receptors (nAChRs) expressed on mesostriatal dopaminergic neurons are thought to mediate several behavioral effects of nicotine, including locomotion, habit learning, and reinforcement. Using immunoprecipitation and ligand-binding techniques, we have shown that both alpha6beta2* and alpha4(nonalpha6)beta2* nAChRs are expressed in the caudate-putamen and that only alpha6* nAChRs can bind alpha-conotoxin MII and methyllycaconitine with affinities of 1.3 and 40 nm, respectively. Further studies performed on 6-hydroxydopamine-lesioned striatum led to the identification of nAChR subtypes selectively expressed on dopaminergic terminals [alpha4alpha5beta2, alpha4alpha6beta2(beta3), and alpha6beta2(beta3)], nondopaminergic neuronal structures (alpha2alpha4beta2), or both structures (alpha4beta2). The identification of the nAChRs expressed on striatal dopaminergic terminals opens up the possibility of developing selective nAChR ligands active on dopaminergic systems and associated diseases, such as Parkinson's disease.
- Published
- 2002
45. Potent Antiglioblastoma Agents by Hybridizing the Onium-Alkyloxy-Stilbene Based Structures of an α7-nAChR, α9-nAChR Antagonist and of a Pro-Oxidant Mitocan
- Author
-
Vanessa Mucchietto, Susanna Pucci, Milena Moretti, Carmen Lammi, Clara De Palma, J. Michael McIntosh, Francesca Fasoli, Roberta Budriesi, Irene Corradini, Donatella Lattuada, Francesco Clementi, Cristiano Bolchi, Cheryl Dowell, Francesco Bavo, Paola Viani, Cecilia Gotti, Marco Pallavicini, Bavo, Francesco, Pucci, Susanna, Fasoli, Francesca, Lammi, Carmen, Moretti, Milena, Mucchietto, Vanessa, Lattuada, Donatella, Viani, Paola, De Palma, Clara, Budriesi, Roberta, Corradini, Irene, Dowell, Cheryl, McIntosh, J. Michael, Clementi, Francesco, Bolchi, Cristiano, Gotti, Cecilia, and Pallavicini, Marco
- Subjects
0301 basic medicine ,Pterostilbene ,alpha7 Nicotinic Acetylcholine Receptor ,Stereochemistry ,Ether ,Antineoplastic Agents ,Receptors, Nicotinic ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Cell Line, Tumor ,Drug Discovery ,Stilbenes ,Humans ,Receptor ,Acetylcholine receptor ,Cell Proliferation ,Drug Discovery3003 Pharmaceutical Science ,Antagonist ,030104 developmental biology ,Nicotinic agonist ,chemistry ,Cell culture ,030220 oncology & carcinogenesis ,Molecular Medicine ,Glioblastoma ,Reactive Oxygen Species ,Linker - Abstract
Adenocarcinoma and glioblastoma cell lines express α7- and α9α10-containing nicotinic acetylcholine receptors (nAChRs), whose activation promotes tumor cell growth. On these cells, the triethylammoniumethyl ether of 4-stilbenol MG624, a known selective antagonist of α7 and α9α10 nAChRs, has antiproliferative activity. The structural analogy of MG624 with the mitocan RDM-4′BTPI, triphenylphosphoniumbutyl ether of pterostilbene, suggested us that molecular hybridization among their three substructures (stilbenoxy residue, alkylene linker, and terminal onium) and elongation of the alkylene linker might result in novel antitumor agents with higher potency and selectivity. We found that lengthening the ethylene bridge in the triethylammonium derivatives results in more potent and selective toxicity toward adenocarcinoma and glioblastoma cells, which was paralleled by increased α7 and α9α10 nAChR antagonism and improved ability of reducing mitochondrial ATP production. Elongation of the alkylene linker was advantageous also for the triphenylphosphonium derivatives resulting in a generalized enhancement of antitumor activity, associated with increased mitotoxicity.
- Published
- 2018
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.